Neurogenetics researchers focus on identifying and understanding the genetic factors that influence neurological development and disorders. Employing advanced technologies such as genome sequencing, CRISPR gene editing, and molecular biology, they investigate how specific gene mutations and variations contribute to conditions like epilepsy, Alzheimer’s disease, Huntington’s disease, and hereditary neuropathies. Their research helps reveal the biological pathways involved in these disorders, paving the way for targeted therapies and personalized medicine. By pinpointing genetic markers linked to disease risk and progression, neurogenetics researchers improve diagnostic accuracy and treatment efficacy. Neurogenetics researchers collaborate with clinicians, genetic counselors, and bioinformaticians to translate discoveries into clinical practice. This teamwork facilitates genetic testing, counseling, and the development of gene-based therapies, including gene editing and pharmacogenomics. Their research also explores gene-environment interactions to better understand disease triggers and develop prevention strategies. Through these efforts, neurogenetics researchers significantly contribute to advancing neuroscience, improving patient care, and offering hope for cures to complex neurological diseases. Their work continually expands the frontiers of medicine, bringing new possibilities for managing inherited neurological conditions. As genetic technologies evolve, their role becomes increasingly vital in shaping the future of neurological healthcare and personalized treatment plans. Their commitment to innovation is driving breakthroughs that could transform lives worldwide.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States